Algodystrophy of the hip is a rare disease. In 1981 Doury et al.' reviewed 160 reported cases but suggested that the condition may be more prevalent because it is often misdiagnosed. In its classic and complete form the disease is frequently unilateral, predominantly on the left.1 2 Males are usually affected in their 40sl-3 and women during pregnancy.45 It begins with a sudden or progressive onset of pain in the groin, the trochanteric region, the thigh, or the knee. There is often a limp and a functional weakness of the affected limb with paradoxical slight pain.6 Three to 6 weeks 1 3after the onset of symptoms x-rays may show a diffuse or spotty regional osteoporosis of the femoral head and acetabulum. Repair takes 4 to 7 months3 67 The erythrocyte sedimentation rate (ESR) and acute-phase reactants are usually within normal limits.
The condition sometimes follows trauma and becomes a form of reflex dystrophy, but usually no precipitating factors are found.' 6 The succession of pathological events which leads to the syndrome is not well known. It is thought that local 'circulatory disturbances' of neurosympathetic origin might play a major role in the bone remodelling.4 I Lequesne 3 in 1968 was the first who employed the term 'transient osteoporosis of the hip.' After Lequesne a series of French publications1 3 67 910 arrived at a consensus that the disorder is probably the equivalent of a reflex dystrophy (Sudeck type) at the hip joint. They coined the term 'algodystrophy' in preference to 'osteoporosis,' stating that certain forms of the disease are inapparent radiologically, being diagnosed by technetium bone scanning, which shows increased uptake due to active bone resorption and apposition in the trabeculae.1 9 10 We report here the development of algodystrophy of the hip in 3 brothers.
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Case reports
The 3 brothers, who had been living separately for more than 10 years in Switzerland, were born in a village in south-west Italy. PATIENT 
1
In March 1980 the patient, aged 39, without previous trauma complained of limping and of moderate pain in the right inguinal and trochanteric region which was relieved by anti-inflammatory drugs. There was a right-leg limp and hypotonia of the right quadriceps.
External rotation was slightly reduced; passive internal rotation and combined flexion-abductionrotation were painful. Mild osteoporosis of the right femoral head was present on a pelvic film in April 1980 ( Fig. 1) In June 1982 a similar painful episode affected the right thigh distally. A bone scan showed increased uptake in the right knee (Fig. 4) . PATIENT 3 In December 1978 the third brother, aged 30, rapidly developed pain in the right hip radiating to the knee / .~~~~~~~~~~~~~~~~4 __ Ad._S and began limping. After 4 months of bed rest his condition spontaneously improved.
In September 1981, when we first saw the patient, there was 1.5 cm atrophy of the right quadriceps. X-rays in March 1979 (Fig. 5) showed osteoporosis in the upper external quarter of the femoral head without any alteration of the interarticular line. This demineralisation remained localised until its disappearance on subsequent films. Retrospectively we diagnosed transient osteoporosis of the hip. In April 1982 the pain and limping recurred on the left side, with a feeling of heaviness and weakness of the thigh. Mobility of the left hip was normal, but movement triggered pain over the trochanter. In June 1982 a bone scan showed increased uptake in the left femoral head (Fig. 6) . He was treated by salmon calcitonin with good clinical results.
LABORATORY FINDINGS
The following tests were normal in all 3 subjects: uric acid, erythrocyte sedimentation rate, complete blood count, fasting blood sugar, thyroid hormone levels, cholesterol, triglyceride, serum lipid electrophoresis, and platelet aggregation. Hydroxyproline excretion was normal.
HLA grouping showed an identical formula: A 1-30 or 31; B 8-37; BW 4-6; DR 7-X; MT 3-1,2 in all 3 subjects (National Laboratory of Swisstransplant, Geneva).
Discussion
None of the patients gave any history of trauma, fever, or systemic disease. We failed to find any of the factors usually predisposing to algodystrophy: diabetes, hyperlipidaemia, anxiety, or depression. They had not been taking drugs before the episodes. There was no evidence of cardiac, endocrine, pulmonary, or Three brothers with algodystrophy ofthe hip 423 neurological disease. Another striking fact was the identity of the HLA formula in all 3 brothers, a rare coincidence.
The relationship between HLA type and algodystrophy has not been well documented, and its importance as a risk factor in this condition remains unknown.' It is noteworthy that our patients presented different radiological aspects of the disease. Patient (Fig. 2) . Our second case showed the classic x-ray picture of the disease with a 'phantom' appearance of the femoral head in November 1980 (Fig. 3) , followed in June 1982 by involvement of the right knee (Fig. 4) . Patient 3, in March 1979 (Fig. 5) , showed a highly localised algodystrophy,l 6 10-12 a form in which bone resorption affects only a part of the femoral head without secondary extension during the entire course of the disease. The second attack in April 1982 (Fig. 6 ) remained 'infra-radiological' until June 1982.
CONCLUSION
Algodystrophy can affect both hips either simultaneously or in succession. Patients 1 and 3 presented the latter, alternating form, seen in 20 to 30% of cases,1 6 in which the second 'circulatory disturbance' occurs several months to several years1 after the first and affects the previously spared hip. Bone resorption of the hip may be followed by involvement of the lower limbs,'7 as in our second case. Why algodystrophy in any location rarely affects the same joint twice is unknown.13 It would seem that involvement of a joint protects it from further episodes. This familial presentation of algodystrophy invites us to consider the possible existence of a genetic factor in the development of the disease. 
